Comparison of outcomes for percutaneous coronary intervention in men and women with unprotected left main disease

被引:0
|
作者
Sheng-Wen LIU [1 ]
Chang-Dong GUAN [2 ]
Feng-Huan HU [1 ]
Jue CHEN [1 ]
Ke-Fei DOU [1 ]
Wei-Xian YANG [1 ]
Yong-Jian WU [1 ]
Yue-Jin YANG [1 ]
Bo XU [2 ]
Shu-Bin QIAO [1 ]
机构
[1] Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences
[2] Catheterization Laboratories, Fuwai Hospital, National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences
关键词
CAD; PCI; Comparison of outcomes for percutaneous coronary intervention in men and women with unprotected left main disease;
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Percutaneous coronary intervention(PCI) in patients with unprotected left main coronary artery disease(ULMCAD) is increasing strategy in coronary artery patients. However, there is a lack of knowledge on the impact of sex on outcomes of patients undergoing ULMCAD PCI.METHODS From January 2004 to December 2015, there were 3,960 patients undergoing ULMCAD PCI at our institution, including 3,121(78.8%) men and 839(21.2%) women. The clinical outcome included the incidence of major adverse cardiac events(MACE)(the composite of all-cause death, myocardial infarction(MI), and revascularization), all-cause death, MI, revascularization at three years follow-up.RESULTS Compared with men, women had not significantly different MACE(14.7% vs. 14.6%, P = 0.89, all-cause death(3.5%vs. 3.7%, P = 0.76), MI(5.0% vs. 4.3%, P = 0.38), revascularization(9.1% vs. 8.9%, P = 0.86), respectively. After adjustment, rates of MACE(HR = 1.49; 95% CI: 1.24-1.81; P < 0.000 1) and all-cause death(HR = 1.65; 95% CI: 1.09-2.48; P = 0.017) occurred more frequently in male patients, as well as revascularization(HR = 1.46; 95% CI: 1.16-1.85; P = 0.001).CONCLUSION In this analysis, compared to men, women undergoing ULMCAD PCI have better outcomes of MACE, allcause death, and revascularization.
引用
收藏
页码:168 / 174
页数:7
相关论文
共 50 条
  • [41] Successful Percutaneous Coronary Intervention in Very High Risk Patient with Critical Left Main, Three-vessel Disease, and Chronic Total Occlusion
    Wardhani, A.
    Cahyadi, M. H.
    Hutomo, A. S.
    Safir
    Rifqi, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0F) : F117 - F117
  • [42] Left Main Coronary Artery Revascularization in Patients with Impaired Renal Function; Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting
    Daoulah, Amin
    Baqais, Rasha Taha
    Aljohar, Alwaleed
    Alhassoun, Abdulkarim
    Hersi, Ahmad S.
    Almahmeed, Wael
    Yousif, Nooraldaem
    Alasmari, Abdulaziz
    Alshehri, Mohammed
    Eltaieb, Fakhreldein
    Alzahrani, Badr
    Elmahrouk, Ahmed
    Arafat, Amr A.
    Jamjoom, Ahmed
    Alshali, Khalid Z.
    Abuelatta, Reda
    Ahmed, Waleed A.
    Alqahtani, Abdulrahman H.
    Al Garni, Turki
    Hashmani, Shahrukh
    Dahdouh, Ziad
    Refaat, Wael
    Kazim, Hameedullah M.
    Ghani, Mohamed Ajaz
    Amin, Haitham
    Hiremath, Niranjan
    Elmahrouk, Youssef
    Selim, Ehab
    Aithal, Jairam
    Qutub, Mohammed A.
    Alama, Mohamed N.
    Ibrahim, Ahmed M.
    Elganady, Abdelmaksoud
    Abohasan, Abdulwali
    Asrar, Farhan M.
    Farghali, Tarek
    Jameel Naser, Maryam
    Hassan, Taher
    Balghith, Mohammed
    Hussien, Adnan Fathey
    Abdulhabeeb, Ibrahim A. M.
    Ahmad, Osama
    Ramadan, Mohamed
    Ghonim, Ahmed A.
    Shawky, Abeer M.
    Noor, Husam A.
    Haq, Ejazul
    Alqahtani, Abdulrahman M.
    Al Samadi, Faisal
    Abualnaja, Seraj
    KIDNEY & BLOOD PRESSURE RESEARCH, 2023, 48 (01) : 545 - 555
  • [43] Impact of diabetes and hypertension on cardiovascular outcomes in patients with coronary artery disease receiving percutaneous coronary intervention
    Lin, Mao-Jen
    Chen, Chun-Yu
    Lin, Hau-De
    Wu, Han-Ping
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [44] Impact of diabetes and hypertension on cardiovascular outcomes in patients with coronary artery disease receiving percutaneous coronary intervention
    Mao-Jen Lin
    Chun-Yu Chen
    Hau-De Lin
    Han-Ping Wu
    BMC Cardiovascular Disorders, 17
  • [45] Revascularization in Left Main Coronary Artery Disease
    Maffey, Max W.
    Ybarra, Luiz F.
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2023, 25 (07) : 205 - 218
  • [46] Revascularization in Left Main Coronary Artery Disease
    Max W. Maffey
    Luiz F. Ybarra
    Current Treatment Options in Cardiovascular Medicine, 2023, 25 (7) : 205 - 218
  • [47] Coronary artery bypass graft surgery versus percutaneous coronary intervention with drug-eluting stents for left main coronary artery disease: A meta-analysis of randomized trials
    Putzu, Alessandro
    Gallo, Michele
    Martino, Enrico Antonio
    Ferrari, Enrico
    Pedrazzini, Giovanni
    Moccetti, Tiziano
    Cassina, Tiziano
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 241 : 142 - 148
  • [48] Impact of sleep deprivation on the outcomes of percutaneous coronary intervention
    Iverson, Ann
    Stanberry, Larissa
    Garberich, Ross
    Antos, Amber
    Sandoval, Yader
    Burke, M. Nicholas
    Chavez, Ivan
    Goessl, Mario
    Henry, Timothy D.
    Lips, Daniel
    Mooney, Michael
    Poulose, Anil
    Sorajja, Paul
    Traverse, Jay
    Wang, Yale
    Bradley, Steven
    Brilakis, Emmanouil S.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (06) : 1118 - 1125
  • [49] Clopidogrel use in coronary heart disease and percutaneous coronary intervention
    Atiemo, Andrew D.
    Williarns, Marlene S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (04) : 689 - 700
  • [50] Left atrial intramural hematoma after percutaneous coronary intervention
    Takaki, Jun
    Yoshinaga, Takashi
    Nishigawa, Kosaku
    Okamoto, Ken
    Fukui, Toshihiro
    CLINICAL CASE REPORTS, 2021, 9 (08):